349 related articles for article (PubMed ID: 23867625)
41. Chemokine-Like Receptor 1 Is a Novel Wnt Target Gene that Regulates Mesenchymal Stem Cell Differentiation.
Muruganandan S; Govindarajan R; McMullen NM; Sinal CJ
Stem Cells; 2017 Mar; 35(3):711-724. PubMed ID: 27733019
[TBL] [Abstract][Full Text] [Related]
42. Attenuated Wnt/β-catenin signalling mediates methotrexate chemotherapy-induced bone loss and marrow adiposity in rats.
Georgiou KR; King TJ; Scherer MA; Zhou H; Foster BK; Xian CJ
Bone; 2012 Jun; 50(6):1223-33. PubMed ID: 22484100
[TBL] [Abstract][Full Text] [Related]
43. Functional interaction between beta-catenin and FOXO in oxidative stress signaling.
Essers MA; de Vries-Smits LM; Barker N; Polderman PE; Burgering BM; Korswagen HC
Science; 2005 May; 308(5725):1181-4. PubMed ID: 15905404
[TBL] [Abstract][Full Text] [Related]
44. Perturbed differentiation of murine embryonic stem cells upon Pelota deletion due to dysregulated FOXO1/β-catenin signaling.
Elkenani M; Nyamsuren G; Toischer K; Adham IM; Mohamed BA
FEBS J; 2021 May; 288(10):3317-3329. PubMed ID: 33245852
[TBL] [Abstract][Full Text] [Related]
45. Chrysosplenetin promotes osteoblastogenesis of bone marrow stromal cells via Wnt/β-catenin pathway and enhances osteogenesis in estrogen deficiency-induced bone loss.
Hong G; He X; Shen Y; Chen X; Yang F; Yang P; Pang F; Han X; He W; Wei Q
Stem Cell Res Ther; 2019 Aug; 10(1):277. PubMed ID: 31464653
[TBL] [Abstract][Full Text] [Related]
46. Redox regulation of FoxO transcription factors.
Klotz LO; Sánchez-Ramos C; Prieto-Arroyo I; Urbánek P; Steinbrenner H; Monsalve M
Redox Biol; 2015 Dec; 6():51-72. PubMed ID: 26184557
[TBL] [Abstract][Full Text] [Related]
47. Maturation of cortical bone suppresses periosteal osteoprogenitor proliferation in a paracrine manner.
Moon YJ; Yun CY; Lee JC; Kim JR; Park BH; Cho ES
J Mol Histol; 2016 Oct; 47(5):445-53. PubMed ID: 27394426
[TBL] [Abstract][Full Text] [Related]
48. Wnt activation protects against neomycin-induced hair cell damage in the mouse cochlea.
Liu L; Chen Y; Qi J; Zhang Y; He Y; Ni W; Li W; Zhang S; Sun S; Taketo MM; Wang L; Chai R; Li H
Cell Death Dis; 2016 Mar; 7(3):e2136. PubMed ID: 26962686
[TBL] [Abstract][Full Text] [Related]
49. Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity.
Hoogeboom D; Essers MA; Polderman PE; Voets E; Smits LM; Burgering BM
J Biol Chem; 2008 Apr; 283(14):9224-30. PubMed ID: 18250171
[TBL] [Abstract][Full Text] [Related]
50. A novel Sprouty4-ERK1/2-Wnt/β-catenin regulatory loop in marrow stromal progenitor cells controls osteogenic and adipogenic differentiation.
Tian L; Xiao H; Li M; Wu X; Xie Y; Zhou J; Zhang X; Wang B
Metabolism; 2020 Apr; 105():154189. PubMed ID: 32105664
[TBL] [Abstract][Full Text] [Related]
51. Formononetin, an isoflavone, activates AMP-activated protein kinase/β-catenin signalling to inhibit adipogenesis and rescues C57BL/6 mice from high-fat diet-induced obesity and bone loss.
Gautam J; Khedgikar V; Kushwaha P; Choudhary D; Nagar GK; Dev K; Dixit P; Singh D; Maurya R; Trivedi R
Br J Nutr; 2017 Mar; 117(5):645-661. PubMed ID: 28367764
[TBL] [Abstract][Full Text] [Related]
52. The Role of FoxOs in Bone Health and Disease.
Kim HN; Iyer S; Ring R; Almeida M
Curr Top Dev Biol; 2018; 127():149-163. PubMed ID: 29433736
[TBL] [Abstract][Full Text] [Related]
53. FoxO1 expression in osteoblasts modulates bone formation through resistance to oxidative stress in mice.
Zhang Y; Xiong Y; Zhou J; Xin N; Zhu Z; Wu Y
Biochem Biophys Res Commun; 2018 Sep; 503(3):1401-1408. PubMed ID: 30025894
[TBL] [Abstract][Full Text] [Related]
54. Forkhead box, class O transcription factors in brain: regulation and behavioral manifestation.
Polter A; Yang S; Zmijewska AA; van Groen T; Paik JH; Depinho RA; Peng SL; Jope RS; Li X
Biol Psychiatry; 2009 Jan; 65(2):150-9. PubMed ID: 18823877
[TBL] [Abstract][Full Text] [Related]
55. Forkhead transcription factors (FoxOs) promote apoptosis of insulin-resistant macrophages during cholesterol-induced endoplasmic reticulum stress.
Senokuchi T; Liang CP; Seimon TA; Han S; Matsumoto M; Banks AS; Paik JH; DePinho RA; Accili D; Tabas I; Tall AR
Diabetes; 2008 Nov; 57(11):2967-76. PubMed ID: 18728232
[TBL] [Abstract][Full Text] [Related]
56. Nuclear factor I-C reciprocally regulates adipocyte and osteoblast differentiation
Zhou J; Wang S; Qi Q; Yang X; Zhu E; Yuan H; Li X; Liu Y; Li X; Wang B
FASEB J; 2017 May; 31(5):1939-1952. PubMed ID: 28122918
[TBL] [Abstract][Full Text] [Related]
57. Deletion of phospholipase D1 decreases bone mass and increases fat mass via modulation of Runx2, β-catenin-osteoprotegerin, PPAR-γ and C/EBPα signaling axis.
Kang DW; Hwang WC; Noh YN; Che X; Lee SH; Jang Y; Choi KY; Choi JY; Min DS
Biochim Biophys Acta Mol Basis Dis; 2021 May; 1867(5):166084. PubMed ID: 33497821
[TBL] [Abstract][Full Text] [Related]
58. Wnt/ß-catenin-mediated p53 suppression is indispensable for osteogenesis of mesenchymal progenitor cells.
Zhou X; Beilter A; Xu Z; Gao R; Xiong S; Paulucci-Holthauzen A; Lozano G; de Crombrugghe B; Gorlick R
Cell Death Dis; 2021 May; 12(6):521. PubMed ID: 34021120
[TBL] [Abstract][Full Text] [Related]
59. Determination of mesenchymal stem cell fate by pigment epithelium-derived factor (PEDF) results in increased adiposity and reduced bone mineral content.
Gattu AK; Swenson ES; Iwakiri Y; Samuel VT; Troiano N; Berry R; Church CD; Rodeheffer MS; Carpenter TO; Chung C
FASEB J; 2013 Nov; 27(11):4384-94. PubMed ID: 23887690
[TBL] [Abstract][Full Text] [Related]
60. FOXO1 inhibits osteoclastogenesis partially by antagnozing MYC.
Tan P; Guan H; Xie L; Mi B; Fang Z; Li J; Li F
Sci Rep; 2015 Nov; 5():16835. PubMed ID: 26568463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
